[ASAP] Alzheimer’s Disease Immunotherapy and Mimetic Peptide Design for Drug Development: Mutation Screening, Molecular Dynamics, and a Quantum Biochemistry Approach Focusing on Aducanumab::Aβ2–7 Binding Affinity

AI Summary

This article discusses the development of immunotherapy and mimetic peptide design for Alzheimer's disease treatment. It focuses on mutation screening, molecular dynamics, and a quantum biochemistry approach specifically looking at the binding affinity between Aducanumab and Aβ2-7. This research aims to improve drug development for Alzheimer's disease.